Anzeige
Mehr »
Login
Montag, 30.09.2024 Börsentäglich über 12.000 News von 691 internationalen Medien
Von 0,059 € auf 0,26 €: Die Gold-Aktie, die alle Erwartungen übertrifft
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 904974 | ISIN: FR0000060873 | Ticker-Symbol: BED
Tradegate
27.09.24
10:43 Uhr
3,760 Euro
-0,060
-1,57 %
Branche
Getränke/Tabak
Aktienmarkt
Sonstige
1-Jahres-Chart
MARIE BRIZARD WINE & SPIRITS SA Chart 1 Jahr
5-Tage-Chart
MARIE BRIZARD WINE & SPIRITS SA 5-Tage-Chart
RealtimeGeldBriefZeit
3,7703,84029.09.
3,8103,83027.09.
GlobeNewswire (Europe)
64 Leser
Artikel bewerten:
(0)

Marie Brizard Wine & Spirits: H1 2024 earnings

Charenton-le-Pont, 26 September 2024

H1 2024 earnings

Resilience in earnings despite the confirmed slowdown of the spirits market and the decline in consumer demand

  • EBITDA1 of €8.5m in H1 2024, up €0.3m from €8.1m in H1 2023
  • Net profit (Group share) of €6.5m in H1 2024, up €1.4m

Marie Brizard Wine & Spirits (the "Company") (Euronext: MBWS) today announces its consolidated earnings for H1 2024 as approved by the Group's Board of Directors today. The audit procedures have been carried out.

Fahd Khadraoui, Chief Executive Officer of MBWS, said: "Faced with difficult market conditions and headwinds, we achieved a good performance, with a growth in our EBITDA and net income in the first half of 2024. However, the improvement in our Gross Margin rate of +1.5 percentage point vs. 2023 is only partial, as we are still lagging below the Gross Margin rate level of the first half of 2022, before the impact of the wave of inflation.

This performance is the result of the efforts of our teams, who were able to focus on our Group's fundamentals while rigorously controlling our costs and staying true to our core offering. Our International Strategic and Regional Stars brands proved resilient amid a complex environment. Moreover, our Industrial Services and third-party brand distribution offerings continue to shore up our own-brand business.

Thanks to our investments in innovation, productivity and competitiveness, we are well positioned to achieve a sustainable growth over the long term, despite a complex short-term context, which sees coming up considerable increases in the cost prices of ageing liquids that were distilled during the inflationary period (particularly Whisky and Cognac).

I would like to thank our teams for their commitment and dedication in making these improvements possible."

Simplified income statement - H1 2024

€m except EPSH1 2023 H1 2024Change

2024 vs 2023
Net revenues (excluding excise duties)98.8 94.9-3.9%
Gross margin36.2 36.2-
Gross margin ratio36.6% 38.1%+1.5 pp
EBITDA8.1 8.5+0.3
Underlying operating profit5.4 5.2-0.2
Net profit (Group share)5.1 6.5+1.4
Earnings per share0.05 0.06

First half 2024 revenues

First half 2024 revenues excluding excise duties came to €94.9m, down 3.9% versus H1 2023 (excluding currency impact). This decline in sales is mainly due to a slowdown in international business, particularly in Europe during the second quarter, albeit partly offset by strong resilience among strategic brands in France.

The France Cluster posted first half 2024 revenues of €42.5m, up 1.1% versus H1 2023 despite the continued slowdown in the spirits market.

  • Sales increased across the William Peel, Marie Brizard and Sobieski brands, both in the Off-Trade segment and On-Trade one, which posted a solid performance during the second quarter.
  • The Marie Brizard brand posted an increase in sales thanks to new listings.
  • H1 2024 revenues for the France Cluster continued to benefit from the price increases introduced on 1 March 2023 and from a base effect linked to stock-outs in Q1 2023.
  • Sales also benefited from a stocking effect with customers at the end of the half-year in preparation for the Paris 2024 Olympic Games.

International revenues amounted to €52.4m in H1 2024, down 7.6% versus H1 2023 at constant exchange rates, reflecting contrasting trends across regions:

  • Revenues from European subsidiaries were down overall in Q2 2024, particularly across the Group's brands (in Spain and to a lesser extent Lithuania, despite an increase in Scandinavia). The solid performance from the subcontracting business in Spain failed to offset the decline in revenues in the Industrial Services segment, which was penalised by falling ethanol bulk unit sale prices in Lithuania and by destocking by some of our brand-owning partners in Bulgaria.
  • Across the Atlantic, sales of Sobieski brand products in the United States were up versus H1 2023, unlike the Marie Brizard brand, for which the distributor reduced its inventory. In Brazil, revenues continued to grow despite the impact of high inflation and declining buying power on volumes.
  • The decline in sales across the various export markets was confirmed, particularly in the Asia Pacific region (primarily due to the Australian, Korean and Taiwanese markets) and in Europe, where the strong Q1 2024 performance in Benelux, Italy and Germany failed to continue into the second quarter, while sales in Poland remained sluggish over the period.

First half 2024 earnings

As growth slowed across the wines and spirits sector, the gross margin ratio was 38.1% in H1 2024 compared to 36.6% in H1 2023. This 150 bp increase reflects our cost control initiative and rigorous sales.

First half 2024 EBITDA amounted to €8.5m, up €0.3 million from H1 2023 (excluding currency impact).

The France Cluster posted EBITDA of €6.1m in H1 2024, up from €6.0m in H1 2023. This improvement reflects the slight growth in Cluster revenues, despite the sluggish market, and continued control of production costs and structural costs.

Meanwhile, the International Cluster posted EBITDA of €4.1m, stable compared to H1 2023. The Lithuanian subsidiary's decline in profitability during the first half, mainly due to temporary difficulties in the bulk and export markets, was offset by growth in the Industrial Services segment in Spain, along with increased profitability in Brazil in line with the subsidiary's plan to improve EBITDA.

Group EBITDA also benefited from the stabilisation of the Holding company's internal costs, resulting in a €1.8m EBITDA loss for the first half of 2024 compared to a €1.9m loss the previous year.

H1 2024 EBITDA by cluster

€mH1 2023LFL changeCurrency impactH1 2024LFL change
(excl. currency
impact)
Reported growth (incl. currency impact)
France6.00.1-6.1+2.4%+2.4%
International4.10.00.04.1+0.5%+0.5%
Holding company(1.9)0.2-(1.8)+8.6%+8.6%
TOTAL MBWS GROUP8.10.30.08.5+4.0%+4.0%

First half net profit, Group share amounted to €6.5m, up €1.4m over H1 2023. This increase was due to an improvement in operating profit and net financial income, bolstered by optimised cash investments.

Balance sheet at 30 June 2024

Shareholders' equity (Group share) amounted to €211.0m at 30 June 2024, up from €203.3m at 31 December 2023, while gross debt remained stable at €7.1m. Gross cash and cash equivalents increased slightly to €47.1m at 30 June 2024, as did net cash, which amounted to €40.0m at 30 June 2024 versus €38.3m at 31 December 2023.

Inventory and work-in-progress came to €53.6m at 30 June 2023, posting a considerable €2.9m decline year-on-year, reflecting the return to normal levels of purchasing inflation and control of operating inventory levels. The slight increase in trade receivables versus H1 2023 takes into account the effects of the price increases rolled out in 2023 to offset higher input costs. Furthermore, the programme to ramp up capital expenditure continued into H1 2024.

Outlook

The 2023 financial year confirmed the Group's resilience and flexibility amid an uncertain environment, thus demonstrating the Group's ability to continue posting earnings growth and lay the foundations for the sustainable and profitable development of its business portfolio.

As predicted, the gradual return to normal of the inflationary climate during the first half of 2024 was coupled with a market contraction in terms of both volumes and value, exacerbated by inventory rundowns across the distribution channels. These trends reflect the targeted moderation of consumer purchases. The Group continues to adapt to the elasticity of demand following price adjustments mainly carried out in 2023, while strengthening its innovation and investment approach.

In 2024, although commercial outlook remains unclear for the end of the year, the Group is committed to maintaining the positive trend of EBITDA growth.

It is actively preparing for 2025, which will be affected by the considerable impact of inflation on the ageing liquids produced during the inflationary period. The Group is approaching the future with caution, focusing on profitability through growth initiatives, rigorous commercial and operational management, and tight control of structural costs.

Financial calendar

  • Publication of revenues for the first nine months of 2024: 24 October 2024

Investor and shareholder relations contact
MBWS Group
Emilie Drexler
relations.actionnaires@mbws.com
Tel.: +33 1 43 91 62 40
Press contact
Image Sept
Claire Doligez - Laurent Poinsot
cdoligez@image7.fr - lpoinsot@image7.fr
Tel.: +33 1 53 70 74 70

About Marie Brizard Wine & Spirits

Marie Brizard Wine & Spirits is a wine and spirits group operating in Europe and the United States. Marie Brizard Wine & Spirits stands out for its expertise, a combination of brands with a long tradition and a resolutely innovative spirit. Since the birth of the Maison Marie Brizard in 1755, the Marie Brizard Wine & Spirits Group has developed its brands in a spirit of modernity while respecting their origins. Marie Brizard Wine & Spirits is committed to offering its customers bold and trusted brands full of flavour and experiences. The Group now has a rich portfolio of leading brands in their market segments, including William Peel, Sobieski, Marie Brizard, Cognac Gautier and San José.
Marie Brizard Wine & Spirits is listed on Compartment B of Euronext Paris (FR0000060873 - MBWS) and is part of the EnterNext© PEA-PME 150 index.

APPENDIXH1 2024 Consolidated Financial Statements

Income statement

(€000)H1 2024H1 2023
Revenues115,177116,955
Excise duties(20,243)(18,192)
Net revenues excluding excise duties94,93498,763
Cost of goods sold(58,731)(62,578)
External expenses(12,834)(13,617)
Personnel expense(14,935)(13,894)
Taxes and levies(718)(835)
Depreciation and amortisation charges(3,169)(2,936)
Other operating income1,7951,834
Other operating expenses(1,123)(1,387)
Underlying operating profit5,2195,350
Non-recurring operating income2,2381,440
Non-recurring operating expenses(1,424)(1,489)
Operating profit 6,0325,300
Income from cash and cash equivalents81859
Gross cost of debt(138)(124)
Net cost of debt680(65)
Other financial income200115
Other financial expenses(180)(123)
Net financial income/(expense)700(74)
Profit before tax6,7335,226
Income tax(203)(120)
Net profit/(loss) from continuing operations6,5305,106
Net profit/(loss) from discontinued operations- -
NET PROFIT/(LOSS)6,5305,106
Group share6,5215,102
of which Net profit/(loss) from continuing operations6,5215,102
of which Net profit/(loss) from discontinued operations--
Non-controlling interests94
of which Net profit/(loss) from continuing operations94
of which Net profit/(loss) from discontinued operations--
-
Earnings per share from continuing operations, Group share (€)€0.06€0.05
Diluted earnings per share from continuing operations, Group share (€)€0.06€0.05
Earnings per share, Group share (€)€0.06€0.05
Diluted earnings per share, Group share (€)€0.06€0.05
Weighted average number of shares outstanding111,884,212111,856,360
Diluted weighted average number of shares outstanding111,884,212111,856,360

Balance sheet

Assets
(€000)30/06/202431/12/2023
Non-current assets
Goodwill14,70414,704
Intangible assets74,44576,137
Property, plant and equipment32,84731,206
Financial assets958965
Deferred tax assets2,8582,712
Total non-current assets125,812125,724
Current assets
Inventory and work-in-progress53,64451,546
Trade receivables40,59940,999
Tax receivables6371,217
Other current assets11,42010,852
Current derivatives33083
Cash and cash equivalents47,07845,132
Total current assets153,707149,829
TOTAL ASSETS279,519275,553
Equity & Liabilities
(€000)30/06/202431/12/2023
Shareholders' equity
Share capital156,786156,786
Additional paid-in capital72,81572,815
Consolidated and other reserves(17,561)(26,332)
Translation reserves(8,518)(8,746)
Consolidated net profit/(loss)6,5218,732
Shareholders' equity (Group share)210,043203,254
Non-controlling interests10394
Total shareholders' equity210,146203,348
Non-current liabilities
Employee benefits1,6011,497
Non-current provisions3,5913,738
Long-term borrowings - due in > 1 year3,1262,538
Other non-current liabilities1,5331,577
Deferred tax liabilities200145
Total non-current liabilities10,0519,495
Current liabilities
Current provisions3,0943,633
Long-term borrowings - due in < 1 year863656
Short-term borrowings3,1053,615
Trade and other payables34,05634,094
Tax liabilities95416
Other current liabilities18,10820,241
Current derivatives155
Total current liabilities59,32262,710
TOTAL EQUITY AND LIABILITIES279,519275,553

Cash flow statement.

(€000)H1 2024H1 2023
Total consolidated net profit/(loss)6,5305,106
Depreciation and provisions2,8831,580
Gains/(losses) on disposals and dilution(418)18
Operating cash flow after net cost of debt and tax8,9956,704
Income tax charge/(income)203120
Net cost of debt(667)63
Operating cash flow before net cost of debt and tax8,5306,887
Change in working capital 1 (inventories, trade receivables/payables)(2,553)607
Change in working capital 2 (other items)(1,874)(5,270)
Tax paid/received49(2,317)
Cash flow from operating activities4,153(93)
Purchase of PP&E and intangible assets(2,662)(1,858)
Decrease (increase) in loans and advances granted(11)116
Disposal of PP&E and intangible assets477-
Impact of change in consolidation scope(4)(116)
Cash flow from investment activities(2,200)(1,858)
Capital increase--
New borrowings-37
Borrowings repaid(447)(360)
Net interest (paid)/received599(11)
Net change in short-term debt(463)(55)
Cash flow from financing activities(311)(389)
Impact of exchange rate fluctuations304(263)
Change in cash and cash equivalents1,945(2,603)
Opening cash and cash equivalents45,13347,496
Closing cash and cash equivalents47,07844,893
Change in cash and cash equivalents1,945(2,603)

1 EBITDA = EBIT + depreciation & amortisation + provisions excl. current assets

NB: All revenue growth figures reported herein are at constant exchange rates and consolidation scope, unless otherwise stated. Financial data individually rounded up or down.


© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.